Andrew Ko, MD

Andrew Ko, MD, details the safety profile of Optune Pax in the PANOVA-3 trial for patients with locally advanced pancreatic cancer.

Andrew Ko, MD, professor, Department of Medicine, University of California, San Francisco Helen Diller Comprehensive Cancer Center, discusses exciting data from the 2018 Gastrointestinal Cancers Symposium.